FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer

U.S. Food and Drug Administration approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system.

source https://www.pharmatutor.org/pharma-news/2020/fda-approves-first-therapy-for-treatment-of-low-grade-upper-tract-urothelial-cancer